» Articles » PMID: 15877893

Modulation of Gut Mucosal Biofilms

Overview
Journal Br J Nutr
Date 2005 May 10
PMID 15877893
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Non-digestible inulin-type fructans, such as oligofructose and high-molecular-weight inulin, have been shown to have the ability to alter the intestinal microbiota composition in such a way that members of the microbial community, generally considered as health-promoting, are stimulated. Bifidobacteria and lactobacilli are the most frequently targeted organisms. Less information exists on effects of inulin-type fructans on the composition, metabolism and health-related significance of bacteria at or near the mucosa surface or in the mucus layer forming mucosa-associated biofilms. Using rats inoculated with a human faecal flora as an experimental model we have found that inulin-type fructans in the diet modulated the gut microbiota by stimulation of mucosa-associated bifidobacteria as well as by partial reduction of pathogenic Salmonella enterica subsp. enterica serovar Typhimurium and thereby benefit health. In addition to changes in mucosal biofilms, inulin-type fructans also induced changes in the colonic mucosa stimulating proliferation in the crypts, increasing the release of mucins, and altering the profile of mucin components in the goblet cells and epithelial mucus layer. These results indicate that inulin-type fructans may stabilise the gut mucosal barrier. Dietary supplementation with these prebiotics could offer a new approach to supporting the barrier function of the mucosa.

Citing Articles

The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats.

Ariaee A, Wardill H, Wignall A, Prestidge C, Joyce P Foods. 2024; 13(7).

PMID: 38611345 PMC: 11011263. DOI: 10.3390/foods13071039.


The gut mucin-microbiota interactions: a missing key to optimizing endurance performance.

Clark A, Mach N Front Physiol. 2023; 14:1284423.

PMID: 38074323 PMC: 10703311. DOI: 10.3389/fphys.2023.1284423.


Links between Diet, Intestinal Anaerobes, Microbial Metabolites and Health.

Duncan S, Conti E, Ricci L, Walker A Biomedicines. 2023; 11(5).

PMID: 37239009 PMC: 10216541. DOI: 10.3390/biomedicines11051338.


Modulating the Microbiome for Crohn's Disease Treatment.

Gowen R, Gamal A, Di Martino L, McCormick T, Ghannoum M Gastroenterology. 2023; 164(5):828-840.

PMID: 36702360 PMC: 10152883. DOI: 10.1053/j.gastro.2023.01.017.


Fructan Biosynthesis by Yeast Cell Factories.

Ko H, Sung B, Kim M, Sohn J, Bae J J Microbiol Biotechnol. 2022; 32(11):1373-1381.

PMID: 36310357 PMC: 9720074. DOI: 10.4014/jmb.2207.07062.